Dr. Ryan Wilcox, MD
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Lymphoma
Studies T-Cell Lymphoma
8 reported clinical trials
15 drugs studied
Area of expertise
1Lymphoma
Stage IV
CD30 negative
HTLV-1 positive
2T-Cell Lymphoma
Affiliated Hospitals
Clinical Trials Ryan Wilcox, MD is currently running
Pacritinib
for T-Cell Lymphoma
The main purpose of this study is to determine the effectiveness of the study drug pacritinib in people with relapsed or refractory lymphoproliferative disorders.
Recruiting1 award Phase 27 criteria
Fenretinide
for T-Cell Lymphoma
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Recruiting1 award Phase 1
More about Ryan Wilcox, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ryan Wilcox, MD has experience with
- Rituximab
- Fenretinide
- Pacritinib
- Mogamulizumab
- Pembrolizumab
- ASTX660
Breakdown of trials Ryan Wilcox, MD has run
Lymphoma
Peripheral T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Wilcox, MD specialize in?
Ryan Wilcox, MD focuses on Lymphoma and T-Cell Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CD30 negative.
Is Ryan Wilcox, MD currently recruiting for clinical trials?
Yes, Ryan Wilcox, MD is currently recruiting for 4 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ryan Wilcox, MD has studied deeply?
Yes, Ryan Wilcox, MD has studied treatments such as Rituximab, Fenretinide, Pacritinib.
What is the best way to schedule an appointment with Ryan Wilcox, MD?
Apply for one of the trials that Ryan Wilcox, MD is conducting.
What is the office address of Ryan Wilcox, MD?
The office of Ryan Wilcox, MD is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.